ERBB2 and breast cancer: Although surgery is usually preferred over NAC for operable HR+, HER2– patients because of relatively poor clinical response to chemotherapy in this group of patients; however, in patients with operable HR+, HER2− BC who have large tumors or metastatic lymph nodes, NAC is still considered for downstaging the tumors and nodes and thereby providing more favorable surgical options.